ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-20.00 (-0.73%)
At close: Sep 11, 2026

KOSDAQ:034940 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,3672,3252,0972,0474,5265,749
Short-Term Investments
-198.122,5491,5381,5371,587
Trading Asset Securities
--800.73775.022,3862,849
Cash & Short-Term Investments
2,3672,5235,4474,3618,44910,184
Cash Growth
65.33%-53.69%24.93%-48.39%-17.04%12.59%
Accounts Receivable
18,18317,80818,25020,23022,72720,884
Other Receivables
2,1971,6711,8182,5932,7312,359
Receivables
20,80019,92320,94823,90027,60324,867
Inventory
10,84711,71712,44613,01210,86910,286
Prepaid Expenses
-96.25204.8887.4594.42118.8
Other Current Assets
827.32792.76693.01796.441,1831,048
Total Current Assets
34,84235,05239,74042,15748,20046,504
Property, Plant & Equipment
28,96519,06719,71220,37024,99924,074
Long-Term Investments
3,1583,5343,0682,7922,9353,678
Goodwill
-----46.78
Other Intangible Assets
581.67549.56769803.4806.87795.5
Long-Term Accounts Receivable
--01,0541,054-
Long-Term Deferred Tax Assets
-365.471,3701,4991,401945.32
Other Long-Term Assets
5,8275,9166,6625,5446,0284,049
Total Assets
73,57464,68371,32074,22185,63980,512

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,5793,4864,8655,5014,9943,685
Accrued Expenses
-3,0803,5163,4942,7652,775
Short-Term Debt
21,76222,10520,75014,55014,55412,794
Current Portion of Long-Term Debt
-905.51448.61---
Current Portion of Leases
581.64564.54629.07633.15637.5684.07
Current Unearned Revenue
-73.84140.5153.42122.2788.1
Other Current Liabilities
6,6505,5456,3064,8474,2554,236
Total Current Liabilities
31,57235,75936,65629,17827,32824,263
Long-Term Debt
2,7781,9731,5761,1051,9041,000
Long-Term Leases
1,8311,7571,2851,2131,5831,996
Pension & Post-Retirement Benefits
1,6991,4351,301545.82-1,328
Other Long-Term Liabilities
1,7351,9911,9413,4223,4173,542
Total Liabilities
41,51242,91642,75935,46434,23132,129

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
15,49015,49015,49015,49015,49015,490
Additional Paid-In Capital
63,62163,62163,62163,62163,62163,621
Retained Earnings
-53,654-54,180-47,817-38,175-26,354-29,255
Comprehensive Income & Other
10,14274.0281.6757.0786.2964.05
Total Common Equity
35,60025,00531,37640,99352,84449,920
Minority Interest
-3,538-3,239-2,815-2,235-1,436-1,537
Shareholders' Equity
32,06221,76728,56138,75851,40848,383
Total Liabilities & Equity
73,57464,68371,32074,22185,63980,512

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
26,95227,30524,68917,50118,67816,474
Net Cash (Debt)
-24,585-24,782-19,242-13,141-10,229-6,289
Net Cash Growth
------
Net Cash Per Share
-3969.86-3999.75-3105.27-2120.83-1650.84-1015.09
Filing Date Shares Outstanding
6.256.26.26.26.26.2
Total Common Shares Outstanding
6.256.26.26.26.26.2
Working Capital
3,270-707.593,08412,97920,87222,242
Book Value Per Share
5698.564035.745063.906616.098528.758056.92
Tangible Book Value
35,01824,45630,60740,19052,03749,078
Tangible Book Value Per Share
5605.453947.044939.796486.438398.527920.98
Land
19,6528,8118,8118,8649,4089,329
Buildings
2,71714,61514,75614,73918,17818,129
Machinery
4,09930,79530,69330,23326,89326,807
Construction In Progress
346.63508.12-7.244,1571,430